Quantum News
Sign InSign Up
Back to News
research

MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
MaxCyte reported Q4 2025 earnings with a narrower-than-expected loss of $0.06 per share, beating estimates by $0.03 despite revenue declining 16% year-over-year to $7.3 million. CEO Maher Masoud and CFO Douglas Swirsky led the March 24, 2026, call, highlighting operational challenges amid lower-than-projected revenue, which missed targets by $1.86 million. The company emphasized forward-looking statements, cautioning investors about potential volatility due to market conditions and regulatory factors outlined in SEC filings. Analysts from Stifel, Craig-Hallum, and BTIG participated, probing financial performance and strategic outlook during the earnings discussion. MaxCyte reaffirmed no obligation to update projections unless required by law, signaling cautious guidance for 2026 amid ongoing industry uncertainties.
AI Audio Summary
0:00 / 0:00
Click to play
gabriel-vasiliu-mdzxj9Ea7JM-unsplash.jpg
Quantum News · Media Library

Understand this faster with AI

ChatGPTAsk ChatGPTPerplexityResearch with PerplexityClaudeExplain with ClaudeGrokDiscuss on Grok

SA Transcripts159.11K FollowersFollow5ShareSaveCommentsQ4: 2026-03-24 Earnings SummaryInsightsTranscript InsightsPlay CallPlay CallEPS of -$0.06 beats by $0.03 | Revenue of $7.30M (-16.02% Y/Y) misses by $1.86M MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call March 24, 2026 4:30 PM EDT Company Participants Eric AbdelMaher Masoud - President, CEO & Executive DirectorDouglas Swirsky - Chief Financial OfficerSean Menarguez Conference Call Participants Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research DivisionMatthew Hewitt - Craig-Hallum Capital Group LLC, Research DivisionVidyun Bais - BTIG, LLC, Research DivisionSteven Etoch - Stephens Inc., Research DivisionChad Wiatrowski - TD Cowen, Research Division Presentation Operator Good day, everyone, and welcome to MaxCyte's Fourth Quarter Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded. Now I'll turn the call over to Eric Abdel with Investor Relations. Please proceed.

Eric Abdel Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MaxCyte, we have Maher Masoud, President and Chief Executive Officer; Doug Swirsky, Chief Financial Officer; and Sean Menarguez, Senior Director of Business Development. Earlier today, MaxCyte released financial results for the Fourth Quarter and Full Year ended December 31, 2025. A copy of the press release is available on the company's website. Before we begin, I need to read the following statement. Statements or comments made during this call may be forward-looking statements within the meaning of federal securities laws. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in any forward-looking statements due to a variety of factors, which are discussed in detail in our SEC filings. Except as required by applicable law, the company has no obligation to publicly update any forward-looking statements, whether because of new information, future events or otherwise. And with that, I will turn the call over to Maher. Maher MasoudPresident, CEO & Executive Director

Read Original

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.